1 |
Otero, L., Aguirre, G., Boiani, L., Denicola, A., Rigol, C., Olea-Azar, C., Maya, J. D., Morello, A., Gonzalez, M., Gambino, D. and Cerecetto, H. : Nitrofurylsemicarbazone rhenium and ruthenium complexes as anti-trypanosomal agents. E. J. Med. Chem. 41, 1231 (2006).
DOI
ScienceOn
|
2 |
James, M. K., Christophe, L. M. J. V., Mandana, K., Galina, I. L., Michael, H. G. and Frederick, S. B. : Rational modification of a candidate cancer drug for use against chagas disease. J. Med. Chem. 52, 1639 (2009).
DOI
ScienceOn
|
3 |
Appelbaum, P. C. and Hunter, P. A. : The fluoroquinolone antibacterials: past, present and future perspectives. I. J. Antimicrobial Agents 16, 5 (2000).
DOI
ScienceOn
|
4 |
Rodrigues, C., Batista, A. A., Aucelio, R. Q., Teixeira, L. R., Visentin, L. D. C. and Beraldo, H. : Spectral and electrochemical studies of ruthenium (II) complexes with -methyl- 4-nitrobenzaldehyde and -methyl-4-nitrobenzophenone thiosemicarbazone: Potential anti-trypanosomal agents. Polyhedron 27, 3061 (2008).
DOI
ScienceOn
|
5 |
Belal, F., Al-Majed, A. A. and Al-Obaid, A. M. : Methods of analysis of 4-quinolone antibacterials. Talanta 50, 765 (1999).
DOI
ScienceOn
|
6 |
Zafra-Gmez, A., Garballo, A., Ballesteros, O., Navaln, A. and Garca-Ayuso, L. E. : Simultaneous determination of quinolone antibacterials in bovine milk by liquid chromatography - mass spectrometry. Biomed. Chromatogr. 22, 1186 (2008).
DOI
ScienceOn
|
7 |
Iztok, T. : The interactions of metal ions with quinolone antibacterial agents. Coordination Chem. 232, 27 (2002).
DOI
ScienceOn
|
8 |
Xiang, M., Weicheng, Z. and Reto, B. : Synthesis, in vitro antitrypanosomal and antibacterial activity of phenoxy, phenylthio or benzyloxy substituted quinolones. Bio. Med. Chem. 19, 986 (2009).
DOI
ScienceOn
|
9 |
Cramer, R. D. III, Patterson, D. E. and Bunce, J. D. : Comparative molecular field analysis (CoMFA), 1. Effect of shape on the binding of steroid to carrier proteins. J. Am. Chem. Soc. 110, 5959 (1988).
DOI
ScienceOn
|
10 |
Klebe, G., Abraham, U. and Mietzner, T. : Molecular similarity indexes in a comparativeanalysis (comsia) of drug molecules to correlate and predict their biological-activity. J. Med. Chem. 37, 4130 (1994).
DOI
ScienceOn
|
11 |
Juan, M. B., Maria, S. P., Hector, W. R., Alicia, R. F., Julio, E. E., Ricardo, E. F. and Patricia, P. O. : Treatment with benznidazole or thioridazine in the chronic phase of experimental Chagas disease improves cardiopathy. Int. J. Parasitol. 29, 733 (2007).
|
12 |
Juan, M. B., He'ctor, W. R., Alicia, R. F. and Julio, E. E. : Trypanosoma cruzi reinfections in mice determine the severity of cardiac damage. Int. J. Parasitol. 32, 889 (2002).
DOI
ScienceOn
|
13 |
Castro, J. A., Montalto de Mecca, M. and Bartel, L. C. : Toxic side effects of drugs used to treat Chagas disease (American trypanosomiasis). Hum. Exp. Toxicol. 25, 471 (2006).
DOI
ScienceOn
|
14 |
Silva, J. J. N., Pavanelli, W. R., Gutierrez, S. F. R., Lima, F. C. A., Silva, A. B. F., Silva, J. S. and Franco, D. W. : Complexation of the anti-Trypanosoma cruzi drug benznidazole improves solubility and efficacy. J. Med. Chem. 51, 4104 (2008).
DOI
ScienceOn
|
15 |
Poli, P., Michele, A. M., Annamaria, B., Renato, A. M., Cristina, N. A., Solange, S. Carlo, R. and Tania Maria, A. D. Z. : Cytotoxic and genotoxic effects of megazol, an anti-Chagas disease drug, assessed by different short-term tests. Biochem. 64, 1617 (2002).
|
16 |
Oliver, H., Michael, H. G., Christophe, L. M. J. V. and Frederick, S. B. : The protein farnesyltransferase inhibitor tipifarnib as a new lead for the development of drugs against chagas disease. J. Med. Chem. 48, 5415 (2005).
DOI
ScienceOn
|
17 |
Shimoda, K. : Mechanisms of quinolone phototoxicity. Toxicology Letters 102-103, 369 (1998).
DOI
ScienceOn
|
18 |
Demir, O. and Roitberg, A. E. : Modulation of catalytic function by differential plasticity of the active site: case study of Trypanosoma cruzi trans-sialidase and Trypanosoma rangeli sialidase. Biochem. 48, 3398 (2009).
DOI
ScienceOn
|
19 |
Lesher, G. Y., Froelich, E. J., Gruet, M. D., Bailey, J. H. and Brundage, R. P. : 1,8-Naphthyridine derivatives. A new class of chemotherapeutic agents. J. Med. Chem. 5, 1063 (1962).
DOI
ScienceOn
|
20 |
Herna'ndez-Arteseros, J. A., Barbosa., J., Compano, R. and Prat, M. D. : Analysis of quinolone residues in edible animal products. J. Chromatography A. 945, 1 (2002).
DOI
ScienceOn
|
21 |
Rodigues, P. R., Lane, J. E., Carter, C. E., Bogitsh, B. J., Singh, P. K., Zimmerman, L. J., Molenda, J. J. and Jones, M. M. : Chelating agent inhibition of Trypanosoma cruzi epimastigotes in vitro. J. Inorganic Biochem. 60, 277 (1995).
DOI
ScienceOn
|
22 |
Choe, Y. C., Brinen, L. S., Price, M. S., Engel, J. C., Lange, M., Grisostomi, C., Weston, S. G., Pallai, P. V., Cheng, H., Hardy, L. W., Hartsough, D. S., McMakin, M., Tilton, R. F., Baldinod, C. M. and Craika, C. S. : Development of -keto-based inhibitors of cruzain, a cysteine protease implicated in Chagas disease. Bioorganic Med. Chem. 13, 2141 (2005).
DOI
ScienceOn
|
23 |
Caetano, L. C., Braza, V., Filipin, M. D. V., Santello, F. H., Caetano, L. N., Toldo, M. P. A., Caldeira, J. C. and Jr. Prado, J. C. D. : Effects of repetitive stress during the acute phase of Trypanosoma cruzi infection on chronic Chagas disease in rats. Stress 12, 144 (2009).
DOI
ScienceOn
|
24 |
Otero, L., Vieites, M., Boiani, L., Denicola, A., Rigol, C., Opazo, L., Olea-Azar, C., Maya, J. D., Morello, A., Krauth-siegel, R. L., Piro, O. E., Castellano, E., Gonzalez, M., Gambino, D. and Cerecetto, H. : Novel antitrypanosomal agents based on palladium nitrofurylthiosemicarbazone complexes: DNA and redox metabolism as potential therapeutic targets. J. Med. Chem. 49, 3322 (2006).
DOI
ScienceOn
|
25 |
Wold, S., Johansson, E. and Cocchi, M. : PLS-partial least squares projections to latent structures, in 3D-QSAR in Drug Design: Theory, Methods and Applications (ed. H. Kubinyi), ESCOM, Leiden, pp. 523-550 (1993).
|
26 |
Oliveira, E. C., Stefani, M. M. A., Campos, D. E., Andrade, A. L. S. S., Silva, S. A., Rassi, A. and Luquetti, A. O. : Trypanosoma cruzi stocks isolated from acute Chagas disease patients lead to lethal murine infection. Transactions of the Royal Society of Tropical Medicine and Hygiene 91, 25 (1997).
DOI
ScienceOn
|
27 |
Ricardo, P. F., Maria del carmen, S. G., Carlos, G. A., Monteo'n, V. M., Reyes, P. A. and Rosales-encina, J. L. : Humoral nitric oxide levels and antibody immune response of symptomatic and indeterminate chagas disease patients to commercial and autochthonous Trypanosoma cruzi antigen. Am. J. Trop. Med. Hyg. 58, 715 (1998).
DOI
|
28 |
Mezencev, R., Galizzi, M., Kutschy, P. and Docampo, R. : Trypanosoma cruzi: Antiproliferative effect of indole phytoalexins on intracellular amastigotes in vitro. Exp. Parasitol. 122, 66 (2009).
DOI
ScienceOn
|
29 |
Soung, M. K., Lee, Y. J. and Sung, N. D. : 3D-QSARs of herbicidal 2-N-phenylisoindolin-1-one analogues as a new class of potent inhibitors of protox. Bull. Kor. Chem. Soc. 30, 613 (2009).
DOI
ScienceOn
|
30 |
Vasan, A. and Komaragiri, S. R. : Comparative analysis of simulated annealing, simulated quenching and genetic algorithms for optimal reservoir operation. Applied Soft Computing 9, 274 (2009)
DOI
ScienceOn
|